Effects of Switching from Tamoxifen to Anastrozole on Tamoxifen-Related Endocrine Symptoms and Quality of Life: In Early Breast Cancer Patients

By Massacesi Cristian  

American Journal of Cancer, Vol. 5, Iss. 6, 2006-01 ,pp. : 433-440

Adis International

Access to resources Recommend Favorite

Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 study

By Aihara Tomohiko  

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 379-387

Springer Publishing Company

Access to resources Recommend Favorite

Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole

By Skedgel C.   Rayson D.   Dewar R.   Younis T.  

Breast Cancer Research and Treatment, Vol. 101, Iss. 3, 2007-03 ,pp. : 325-333

Springer Publishing Company

Access to resources Recommend Favorite

Effect of anastrozole and tamoxifen on lipid metabolism in Japanese postmenopausal women with early breast cancer

By Sawada Shojiro   Sato Kazuhiko   Kusuhara Masatoshi   Ayaori Makoto   Yonemura Atsushi   Tamaki Kuniyoshi   Hiraide Hoshio   Mochizuki Hidetaka   Ohsuzu Fumitaka  

Acta Oncologica, Vol. 44, Iss. 2, 2005-03 ,pp. : 134-141

Informa Healthcare

Access to resources Recommend Favorite

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer

By Jansen M.  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 937-947

Springer Publishing Company

Access to resources Recommend Favorite